GSK-Genmab blood cancer drug approved in US

November 2, 2009
Research and Development, Sales and Marketing Arzerra

GlaxoSmithKline and Philadelphia-based Genmab have received accelerated US approval for their blood cancer drug Arzerra. It is to be used …

Lonza cuts staff, issues profits warning

November 2, 2009
Manufacturing and Production CMO

Swiss contract manufacturer and fine chemical firm Lonza has announced it will cut around 5% of its workforce and may …

Synovate Jackie

Jackie Ilacqua, head of oncology, Synovate

November 2, 2009
Sales and Marketing appointment, sales and marketing, synovate

Synovate has appointed Jackie Ilacqua to the newly-created role of head of oncology.Formerly responsible for building and managing Synovate’s global …

AstraZeneca withdraws filings for lung cancer drug

November 2, 2009
Research and Development, Sales and Marketing AZ, zactima

AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …

GSK returns to growth despite US sales hit

October 28, 2009
Sales and Marketing GSK, generics

GlaxoSmithKline suffered a hit in the US during the third quarter of the year, with sales down 12% to £2.14 …

GSK begins phase III COPD trials

October 28, 2009
Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory

GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …

Ipsen Claude

Claude Bertrand joins Ipsen as Chief Scientific Officer

October 27, 2009
Research and Development appointment, ipsen, research and development

Ipsen has appointed Claude Bertrand (pictured) chief scientific officer and Jacques-Pierre Moreau chief scientific advisor.Bertrand moves to the company next …

Merck KGaA’s rising revenues fail to lift bottom line

October 27, 2009
Sales and Marketing Merck Serono

 Revenues up, earnings down: that was the bottom line to Merck KGaA’s financial performance in the three months to the …

Quintiles will open new clinical unit in London next year

October 27, 2009
Research and Development NHS, Quintiles

Quintiles has agreed to set up a clinical research unit in London that will allow it to tap into the …

KateLandscape

New digital agency eBee launched

October 27, 2009
Medical Communications digi pharma

New agency eBee has been launched as a specialist in groundbreaking digital work.The agency is a spin-off subsidiary of Hive …

Consolidation wave likely to continue among European CROs

October 27, 2009
Research and Development cros

Another report concluding that the most successful contract research organisations (CROs) will be those that can offer a broad range …

Contract research news in brief

October 26, 2009
Research and Development cros

Pharmafocus' round-up of contract research news includes ICON's Q3 results, expansion plans at ClinTec and a prestigious award for Bilcare

Critical Pharma gets Wellcome funding for biologic spray technology

October 26, 2009
Research and Development critical pharma

A nasal spray technology which promises an alternative drug delivery method for biologic drugs has been given a funding boost. …

Adventis five

Adventis Health appoints five new staff

October 26, 2009
Medical Communications Adventis, appointment, medical communications

Adventis Health has appointed five new staff – three to its med ed division, one to its advertising division and …

European regulators begin Tysabri review

October 26, 2009
Sales and Marketing EU, Tysabri, reg

European regulators have begun a risk-benefit review of Biogen Idec’s multiple sclerosis drug Tysabri, which has been linked to 23 …

TRB Anna

Anna ‘Lito’ Michala, sales executive, TRB Chemedica UK

October 23, 2009
Sales and Marketing TRB Chemedica, appoinment, appointment, sales and marketing

TRB Chemedica UK has appointed Anna ‘Lito’ Michala as sales executive for Scotland and the North of England.Lito joins the …

European approval for 3-in-1 version of Exforge

October 23, 2009
Sales and Marketing Diovan, Exforge, Novartis, cv, hypertension

European regulators have approved an expanded version of Novartis’ high blood pressure treatment Exforge.Exforge was first approved in Europe in …

Januvia helps stabilise Merck sales

October 23, 2009
Sales and Marketing Januvia, Merck

 Merck has turned in stable figures for the third quarter of the year, with global sales up 2% on the …

The Gateway to Local Adoption Series

Latest content